How has been the historical performance of the Novartis India?

Answer:The historical performance of Novartis India shows a fluctuating trend in key financial metrics over the years.

Breakdown:
Novartis India's net sales have seen a decline from Rs 490.68 crore in March 2019 to Rs 356.27 crore in March 2025, with a notable peak in March 2023 at Rs 378.74 crore. The total operating income followed a similar pattern, decreasing from Rs 490.68 crore in March 2019 to Rs 356.27 crore in March 2025. The operating profit, however, has shown improvement, rising from Rs 12.28 crore in March 2019 to Rs 133.38 crore in March 2025, indicating a stronger operational efficiency with an operating profit margin that increased from 2.5% in March 2019 to 25.66% in March 2025. Profit before tax also improved significantly, reaching Rs 130.42 crore in March 2025, compared to a loss of Rs 3.82 crore in March 2022. The profit after tax has fluctuated, with a low of Rs -3.72 crore in March 2022, but rebounding to Rs 100.90 crore in March 2025. Total assets decreased from Rs 961.00 crore in March 2019 to Rs 909.56 crore in March 2024, while total liabilities also declined from Rs 961.00 crore to Rs 909.56 crore in the same period. Cash flow from operating activities improved significantly, reaching Rs 113.00 crore in March 2024, compared to a negative cash flow in previous years. Overall, while Novartis India has faced challenges in sales and total assets, it has made notable strides in profitability and cash flow management.